F52. EFFICACY AND SAFETY OF LURASIDONE IN ADOLESCENTS WITH SCHIZOPHRENIA: INTERIM ANALYSIS OF A 24-MONTH, OPEN-LABEL EXTENSION STUDY

BACKGROUND: Long-term efficacy and safety data from prospective studies in adolescents with schizophrenia are limited. Lurasidone is an atypical antipsychotic that has demonstrated efficacy in the treatment of schizophrenia in both adults and adolescents. The aim of the current open-label trial was...

Descripción completa

Detalles Bibliográficos
Autores principales: Goldman, Robert, Tocco, Michael, Pikalov, Andrei, Cucchiaro, Josephine, Deng, Ling, Loebel, Antony
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5888173/
http://dx.doi.org/10.1093/schbul/sby017.583

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5888173/
http://dx.doi.org/10.1093/schbul/sby017.583

Ejemplares similares